• Can J Cardiol · Sep 2003

    National Cholesterol Education Program Adult Treatment Panel III guidelines and obesity: implications for Canada.

    • Christopher I Ardern and Peter T Katzmarzyk.
    • School of Physical and Health Education, Queen's University, Kingston, Ontario, Canada.
    • Can J Cardiol. 2003 Sep 1; 19 (10): 1171-7.

    BackgroundThe National Cholesterol Education Program Adult Treatment Panel (ATP) III recommendations incorporate new evidence for treating elevated low-density lipoprotein cholesterol.ObjectivesComparisons between the prevalence of drug-eligible Canadians under the old ATP II and the new ATP III guidelines were made, and the impact of obesity on current and future drug eligibility was explored using various models.MethodsParticipants from the Canadian Heart Health Surveys (1986 to 1992; n=17,728; 20 to 74 years of age) were assigned to therapeutic lifestyle change or drug-eligible groups in the event of elevated low-density lipoprotein cholesterol. Body mass index was used to classify participants as having normal weight, or as being overweight or obese. The prevalence of overweight and obese status for 2001, 2006 and 2011 were projected from past trends by linear regression. Population attributable risk was used to model reductions or increases in the prevalence of obesity in drug-eligible participants using several nationally representative population health surveys.ResultsIn 2001, an additional 1.1 million Canadians were drug-eligible under ATP III (16.0% of men, 9.5% of women), compared with ATP II (7.7% of men, 7.7% of women). Drug eligibility was elevated in overweight participants (men: OR=1.87 [1.51 to 2.31]; women: OR=1.60 [1.13 to 2.28]) and the obese (men: OR=2.86 [1.86 to 4.38]; women: OR=2.28 [1.63 to 3.18]) versus normal weight participants. The population attributable risk was higher in men (overweight 22.6%, obese 11.5%) than in women (overweight 9.4%, obese 9.2%).ImplicationsA 10% reduction in overweight and obesity prevalence could have prevented 69,530 cases of drug eligibility in 2001. On the other hand, by 2011 over one million Canadians will be drug-eligible because of an elevated body mass index, if the recent trends in overweight and obese status continue.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.